secwatch / observer
8-K filed February 4, 2025, 6:59 PM ET CIK 0001708331
leadership confidence high sentiment neutral materiality 0.35

Director Jay Panis resigns from Virpax board and committees, effective Feb 3, 2025

Virpax Pharmaceuticals, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jay Panis

Director
Virpax Pharmaceuticals, Inc.
Effective
2025-02-03
Filed
February 4, 2025, 6:59 PM ET
On February 3, 2025, Mr. Jaydriane (Jay) Panis, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Board of his resignation from the Board and the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jay Panis resigned as Director at Virpax Pharmaceuticals, Inc..

Action
resigned
Role
Director
Exact text from the filing
On February 3, 2025, Mr. Jaydriane (Jay) Panis, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Board of his resignation from the Board and the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001731122-25-000163
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.